BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang J, Wang G, Chu SJ, Zhu JS, Zhang R, Lu WW, Xia LQ, Lu YM, Da W, Sun Q. Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling. Oncotarget 2016;7:16180-93. [PMID: 26921249 DOI: 10.18632/oncotarget.7568] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Tong R, Yang B, Xiao H, Peng C, Hu W, Weng X, Cheng S, Du C, Lv Z, Ding C, Zhou L, Xie H, Wu J, Zheng S. KCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signaling. Oncotarget 2017;8:37717-29. [PMID: 28465479 DOI: 10.18632/oncotarget.17145] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
2 Zhang J, Jin M, Chen X, Zhang R, Huang Y, Liu H, Zhu J. Loss of PPM1F expression predicts tumour recurrence and is negatively regulated by miR-590-3p in gastric cancer. Cell Prolif 2018;51:e12444. [PMID: 29473240 DOI: 10.1111/cpr.12444] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
3 Yin L, Li W, Xu A, Shi H, Wang K, Yang H, Wang R, Peng B. SH3BGRL2 inhibits growth and metastasis in clear cell renal cell carcinoma via activating hippo/TEAD1-Twist1 pathway. EBioMedicine 2020;51:102596. [PMID: 31911271 DOI: 10.1016/j.ebiom.2019.12.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
4 Huang Y, Zhang J, Wang G, Chen X, Zhang R, Liu H, Zhu J. Oxymatrine exhibits anti-tumor activity in gastric cancer through inhibition of IL-21R-mediated JAK2/STAT3 pathway. Int J Immunopathol Pharmacol 2018;32:2058738418781634. [PMID: 30103640 DOI: 10.1177/2058738418781634] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
5 Yan L, Zhang J, Guo D, Ma J, Shui SF, Han XW. IL-21R functions as an oncogenic factor and is regulated by the lncRNA MALAT1/miR-125a-3p axis in gastric cancer. Int J Oncol 2019;54:7-16. [PMID: 30387833 DOI: 10.3892/ijo.2018.4612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
6 Lin SC, Lee HC, Hou PC, Fu JL, Wu MH, Tsai SJ. Targeting hypoxia-mediated YAP1 nuclear translocation ameliorates pathogenesis of endometriosis without compromising maternal fertility. J Pathol 2017;242:476-87. [PMID: 28608501 DOI: 10.1002/path.4922] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
7 Zhang J, Hou L, Liang R, Chen X, Zhang R, Chen W, Zhu J. CircDLST promotes the tumorigenesis and metastasis of gastric cancer by sponging miR-502-5p and activating the NRAS/MEK1/ERK1/2 signaling. Mol Cancer 2019;18:80. [PMID: 30953514 DOI: 10.1186/s12943-019-1015-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 16.3] [Reference Citation Analysis]
8 Plewes MR, Hou X, Zhang P, Liang A, Hua G, Wood JR, Cupp AS, Lv X, Wang C, Davis JS. Yes-associated protein 1 is required for proliferation and function of bovine granulosa cells in vitro†. Biol Reprod 2019;101:1001-17. [PMID: 31350850 DOI: 10.1093/biolre/ioz139] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
9 Yin K, Dang S, Cui L, Fan X, Wang L, Xie R, Qu J, Shang M, Chen J, Xu Z. Netrin-1 promotes metastasis of gastric cancer by regulating YAP activity. Biochem Biophys Res Commun 2018;496:76-82. [PMID: 29305865 DOI: 10.1016/j.bbrc.2017.12.170] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Fang Y. Circular RNAs as novel biomarkers with regulatory potency in human diseases. Future Sci OA 2018;4:FSO314. [PMID: 30112184 DOI: 10.4155/fsoa-2018-0036] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
11 Warren JSA, Xiao Y, Lamar JM. YAP/TAZ Activation as a Target for Treating Metastatic Cancer. Cancers (Basel) 2018;10:E115. [PMID: 29642615 DOI: 10.3390/cancers10040115] [Cited by in Crossref: 72] [Cited by in F6Publishing: 60] [Article Influence: 18.0] [Reference Citation Analysis]
12 Sui X, Liu Z, Niu L, Yin B, Huo C. Hsa_circ_0006677 regulates special AT-rich binding protein-2-mediated tumor-suppressive effect via functioning as a miR-1245a sponge in non-small cell lung cancer. Bioengineered 2022;13:3760-74. [PMID: 35081869 DOI: 10.1080/21655979.2022.2031400] [Reference Citation Analysis]
13 Mei L, Yuan L, Shi W, Fan S, Tang C, Fan X, Yang W, Qian Y, Hussain M, Wu X. SUMOylation of large tumor suppressor 1 at Lys751 attenuates its kinase activity and tumor-suppressor functions. Cancer Lett 2017;386:1-11. [PMID: 27847303 DOI: 10.1016/j.canlet.2016.11.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
14 Qiao Y, Li T, Zheng S, Wang H. The Hippo pathway as a drug target in gastric cancer. Cancer Lett 2018;420:14-25. [PMID: 29408652 DOI: 10.1016/j.canlet.2018.01.062] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
15 Herrera-Pariente C, Capó-García R, Díaz-Gay M, Carballal S, Muñoz J, Llach J, Sánchez A, Bonjoch L, Arnau-Collell C, Soares de Lima Y, Golubicki M, Jung G, Lozano JJ, Castells A, Balaguer F, Bujanda L, Castellví-Bel S, Moreira L. Identification of New Genes Involved in Germline Predisposition to Early-Onset Gastric Cancer. Int J Mol Sci 2021;22:1310. [PMID: 33525650 DOI: 10.3390/ijms22031310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wang T, Zhang P, Li C, Liu W, Shen Q, Yang L, Xie G, Bai J, Li R, Tao K, Yin Y. MUS81 Inhibition Enhances the Anticancer Efficacy of Talazoparib by Impairing ATR/CHK1 Signaling Pathway in Gastric Cancer. Front Oncol 2022;12:844135. [DOI: 10.3389/fonc.2022.844135] [Reference Citation Analysis]
17 Zhang J, Liu H, Hou L, Wang G, Zhang R, Huang Y, Chen X, Zhu J. Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression. Mol Cancer. 2017;16:151. [PMID: 28893265 DOI: 10.1186/s12943-017-0719-3] [Cited by in Crossref: 274] [Cited by in F6Publishing: 305] [Article Influence: 54.8] [Reference Citation Analysis]
18 Tan Y, Li QM, Huang N, Cheng S, Zhao GJ, Chen H, Chen S, Tang ZH, Zhang WQ, Huang Q, Cheng Y. Upregulation of DACT2 suppresses proliferation and enhances apoptosis of glioma cell via inactivation of YAP signaling pathway. Cell Death Dis 2017;8:e2981. [PMID: 28796248 DOI: 10.1038/cddis.2017.385] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
19 Mo J, Nie H, Zeng C, Han H, Xu P, Shi X. Circular RNA circ_0067741 regulates the Hippo/YAP pathway to suppress lung adenocarcinoma progression by targeting microRNA-183-5p. Bioengineered 2022;13:10165-76. [DOI: 10.1080/21655979.2022.2060901] [Reference Citation Analysis]
20 Liu H, Liu N, Zhao Y, Zhu X, Wang C, Liu Q, Gao C, Zhao X, Li J. Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling. Aging (Albany NY) 2019;11:9643-60. [PMID: 31689236 DOI: 10.18632/aging.102410] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
21 Yang C, Tan J, Zhu J, Wang S, Wei G. YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma. Oncotarget 2017;8:37154-63. [PMID: 28415761 DOI: 10.18632/oncotarget.16209] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
22 Zheng J, Liu X, Zheng B, Zheng Z, Zhang H, Zheng J, Sun C, Chen H, Yang J, Wang Z, Lin M, Chen J, Zhou Q, Zheng Z, Xu X, Ying H. Maternal 25-Hydroxyvitamin D Deficiency Promoted Metabolic Syndrome and Downregulated Nrf2/CBR1 Pathway in Offspring. Front Pharmacol 2020;11:97. [PMID: 32184720 DOI: 10.3389/fphar.2020.00097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
23 Chen H, Zhang H, Xie H, Zheng J, Lin M, Chen J, Tong Y, Jin J, Xu K, Yang J, Sun C, Xu X, Zheng J. Maternal, umbilical arterial metabolic levels and placental Nrf2/CBR1 expression in pregnancies with and without 25-hydroxyvitamin D deficiency. Gynecol Endocrinol 2021;37:807-13. [PMID: 34232092 DOI: 10.1080/09513590.2021.1942451] [Reference Citation Analysis]
24 Qadir J, Riaz SK, Taj K, Sattar N, Sahar NE, Khan JS, Kayani MA, Haq F, Arshad Malik MF. Increased YAP1 expression is significantly associated with breast cancer progression, metastasis and poor survival. Future Oncol 2021;17:2725-34. [PMID: 33880946 DOI: 10.2217/fon-2020-1080] [Reference Citation Analysis]
25 Seeneevassen L, Dubus P, Gronnier C, Varon C. Hippo in Gastric Cancer: From Signalling to Therapy. Cancers 2022;14:2282. [DOI: 10.3390/cancers14092282] [Reference Citation Analysis]
26 Wang X, Wu B, Zhong Z. Downregulation of YAP inhibits proliferation, invasion and increases cisplatin sensitivity in human hepatocellular carcinoma cells. Oncol Lett 2018;16:585-93. [PMID: 29928445 DOI: 10.3892/ol.2018.8633] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
27 Han Y, Tang Z, Zhao Y, Li Q, Wang E. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer. Mol Carcinog 2018;57:159-66. [DOI: 10.1002/mc.22740] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
28 Poma AM, Torregrossa L, Bruno R, Basolo F, Fontanini G. Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature. Sci Rep 2018;8:10623. [PMID: 30006603 DOI: 10.1038/s41598-018-28928-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
29 Pan Z, Tian Y, Zhang B, Zhang X, Shi H, Liang Z, Wu P, Li R, You B, Yang L, Mao F, Qian H, Xu W. YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression. Int J Oncol 2017;51:1055-66. [PMID: 28848999 DOI: 10.3892/ijo.2017.4101] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
30 Hou J, Zhou J. WWC3 downregulation correlates with poor prognosis and inhibition of Hippo signaling in human gastric cancer. Onco Targets Ther 2017;10:2931-42. [PMID: 28652775 DOI: 10.2147/OTT.S124790] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
31 Deng YY, Min YJ, Zhou K, Yang QS, Peng M, Cui ZR, Zhu XL, Liu H, Wang M, Zhang X, Liu LX. Identification of the tumor‑suppressive role of circular RNA‑FOXO3 in colorectal cancer via regulation of miR‑543/LATS1 axis. Oncol Rep 2021;46:239. [PMID: 34549306 DOI: 10.3892/or.2021.8190] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Gao J, Pan H, Zhu Z, Yu T, Huang B, Zhou Y. Guanine nucleotide-binding protein subunit beta-4 promotes gastric cancer progression via activating Erk1/2. Acta Biochim Biophys Sin (Shanghai) 2020;52:975-87. [PMID: 32747927 DOI: 10.1093/abbs/gmaa084] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
33 Yamaguchi H, Taouk GM. A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations. Front Oncol 2020;10:928. [PMID: 32596154 DOI: 10.3389/fonc.2020.00928] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
34 Nishio M, Maehama T, Goto H, Nakatani K, Kato W, Omori H, Miyachi Y, Togashi H, Shimono Y, Suzuki A. Hippo vs. Crab: tissue-specific functions of the mammalian Hippo pathway. Genes Cells 2017;22:6-31. [PMID: 28078823 DOI: 10.1111/gtc.12461] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
35 Chen XY, Zhang J, Hou LD, Zhang R, Chen W, Fan HN, Huang YX, Liu H, Zhu JS. Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma. Int J Immunopathol Pharmacol 2018;32:2058738418790318. [PMID: 30045644 DOI: 10.1177/2058738418790318] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
36 Han X, Jia Y, Chen X, Sun C, Sun J. lncRNA TINCR attenuates the proliferation and invasion, and enhances the apoptosis of cutaneous malignant melanoma cells by regulating the miR‑424‑5p/LATS1 axis. Oncol Rep 2021;46:238. [PMID: 34542165 DOI: 10.3892/or.2021.8189] [Reference Citation Analysis]
37 Huang Y, Zhang J, Hou L, Wang G, Liu H, Zhang R, Chen X, Zhu J. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway. J Exp Clin Cancer Res. 2017;36:194. [PMID: 29282102 DOI: 10.1186/s13046-017-0666-2] [Cited by in Crossref: 72] [Cited by in F6Publishing: 85] [Article Influence: 14.4] [Reference Citation Analysis]
38 Zhao WJ, Ou GY, Lin WW. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas. Front Immunol 2021;12:682415. [PMID: 34054873 DOI: 10.3389/fimmu.2021.682415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Li FL, Guan KL. The two sides of Hippo pathway in cancer. Semin Cancer Biol 2021:S1044-579X(21)00200-5. [PMID: 34265423 DOI: 10.1016/j.semcancer.2021.07.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Zhang R, Liu Y, Liu H, Chen W, Fan HN, Zhang J, Zhu JS. The long non-coding RNA SNHG12 promotes gastric cancer by activating the phosphatidylinositol 3-kinase/AKT pathway. Aging (Albany NY) 2019;11:10902-22. [PMID: 31808752 DOI: 10.18632/aging.102493] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
41 Sharif AA, Hergovich A. The NDR/LATS protein kinases in immunology and cancer biology. Seminars in Cancer Biology 2018;48:104-14. [DOI: 10.1016/j.semcancer.2017.04.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
42 Zhou C, Jiang CQ, Zong Z, Lin JC, Lao LF. miR-146a promotes growth of osteosarcoma cells by targeting ZNRF3/GSK-3β/β-catenin signaling pathway. Oncotarget 2017;8:74276-86. [PMID: 29088784 DOI: 10.18632/oncotarget.19395] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]